AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

ORPEA

Legal Proceedings Report Jun 23, 2023

1578_iss_2023-06-23_7e701ad0-cc55-47c5-a424-f621a9f265a2.pdf

Legal Proceedings Report

Open in Viewer

Opens in native device viewer

Puteaux, 23 June 2023 (9:00 pm CEST)

COMMUNICATION TO ORPEA OF TWO EXPERT REPORTS DRAWN UP AT THE REQUEST OF THE INSOLVENCY JUDGE APPOINTED IN THE CONTEXT OF THE ACCELERATED SAFEGUARD PROCEDURE

By order of the court-appointed insolvency judge in the context of ORPEA's accelerated safeguard procedure, the firm Ledouble, acting as an independent financial expert, was appointed to draw up two valuation reports with a view to implementing ORPEA's financial restructuring.

The court-appointed administrators have today sent these reports, intended for the bodies involved in the proceedings, to ORPEA.

These two expert reports relate to:

  • the valuation of the ORPEA group as a going concern: this report leads the independent expert to propose a range of values of between €6 billion and €7 billion;
  • the valuation of ORPEA SA in a liquidation scenario, including a scenario for the sale of individual assets and a scenario for the sale of all ORPEA assets to a acquirer: this report leads the independent expert to consider that the best estimate of liquidation value is comprised between €2.6 billion and €3.7 billion.

These two valuation reports are available on ORPEA's website in the "Restructuring" section [link].

About ORPEA

ORPEA is a leading global player, expert in providing care for all types of frailty. The Group operates in 21 countries and covers three core businesses: care for the elderly (nursing homes, assisted living facilities, homecare and services), post-acute and rehabilitation care and mental health care (specialized clinics). It has more than 76,000 employees and welcomes more than 267,000 patients and residents each year.

https://www.orpea-group.com/en

ORPEA is listed on Euronext Paris (ISIN: FR0000184798) and is a member of the SBF 120 and CAC Mid 60 indices.

Investor Relations Investor Relations Press Relations
ORPEA NewCap ORPEA
Benoit Lesieur Dusan Oresansky Isabelle Herrier-Naufle
Investor Relations Director Tel.: 01 44 71 94 94 Press Relations Director
[email protected] [email protected] Tel.: 07 70 29 53 74

Toll-free number for shareholders:

0 805 480 480

Image7

[email protected]

Charlotte Le Barbier // Laurence Heilbronn 06 78 37 27 60 - 06 89 87 61 37 [email protected] [email protected]

Talk to a Data Expert

Have a question? We'll get back to you promptly.